Vieira B I, Murdock C J, Hendry P J, Stanley F, Davey M G
Aust N Z J Obstet Gynaecol. 1980 May;20(2):69-72. doi: 10.1111/j.1479-828x.1980.tb00095.x.
The prophylactic use of anti-Rh (D) immunoglobulin has resulted in a marked decline in the incidence of Rh haemolytic disease of the newborn (HDN) since its introduction in 1968. Nevertheless, cases still occur. Those recorded in the metropolitan area of Western Australia in the 3 years, 1974 to 1976, have been studied in detail. There were 29 cases of ABO haemolytic disease, among which there were no deaths, and 56 cases of Rh haemolytic disease with 9 perinatal deaths. Nearly half of the mothers of the infants with Rh HDN were first immunised before anti-D became available; a quarter had not been given anti-D when it was required, and a few had formed Rh antibodies in their first pregnancy or despite treatment with anti-D.
自1968年引入抗Rh(D)免疫球蛋白进行预防使用以来,新生儿Rh溶血病(HDN)的发病率显著下降。然而,病例仍有发生。对西澳大利亚州大都市地区1974年至1976年这3年记录的病例进行了详细研究。有29例ABO溶血病,其中无死亡病例;有56例Rh溶血病,围产期死亡9例。Rh HDN患儿的母亲中,近一半在有抗-D之前首次免疫;四分之一在需要时未给予抗-D,少数在首次怀孕时或尽管接受了抗-D治疗仍产生了Rh抗体。